SD-OCT Angiography

NATerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions
Neovascular Age-related Macular DegenerationAge-related Macular DegenerationDiabetic RetinopathyRetinal Vein OcclusionDiabetic Macular Edema
Interventions
DEVICE

AngioVue SD-OCT

OCT-A allows noninvasive, high-resolution imaging of the microvasculature of the retina and choroid, without intravenous dye administration. SD-OCT units use the light source used in commercially available and FDA-cleared OCT units on a modified platform. Optovue, Inc. has developed a customized SD-OCT system that implements a novel algorithm, the amplitude-based method of split-spectrum amplitude-decorrelation angiography (SSADA) for OCT-A. This detects motion in the blood vessel lumen by measuring the variation in reflected OCT signal amplitude between consecutive cross-sectional scans. Optovue has integrated the novel SSADA algorithm into their commercially approved RTVue SD-OCT unit for their OCT-A unit, the AngioVue. This unit is being conducted under an abbreviated IDE.

Trial Locations (1)

27710

Duke Eye Center, Durham

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Optovue

INDUSTRY

lead

Duke University

OTHER